Alpine Associates Management’s Bio-Techne TECH Stock Holding History

Alpine Associates Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.5M	Buy	+502,000	New	+$27.1M	2.22%	15

Other funds holding TECH

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

BTCPP

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Alpine Associates Management's TECH Position: Q2 2026 in Review

Alpine Associates Management opened a new position in Bio-Techne (TECH) in Q2 2026: 502,000 shares worth $35.5M. The stake represents 2.22% of the portfolio and ranks #15 among its holdings.

239 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Alpine Associates Management held 502,000 shares of Bio-Techne worth $35.5M as of Q2 2026.
Bio-Techne was a new Alpine Associates Management position in Q2 2026.
Bio-Techne made up 2.22% of Alpine Associates Management's portfolio in Q2 2026, its #15 holding.
239 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Alpine Associates Management's 13F filing for Q2 2026, filed 6 Aug 2026.